Related Experiment Video
Updated: Feb 7, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Epidemiological and Genomic Insights into Linezolid-Non-Susceptible Enterococci in Pediatric Patients
Chao Fang1, Zheng Zhou1, Xiucai Zhang1
1Department of Clinical Laboratory, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, No. 3333 Binsheng road, Hangzhou, Zhejiang Province, China.
Insights
Linezolid-non-susceptible enterococci (LNSE) are a growing threat in pediatric healthcare. This study reveals key genetic traits of LNSE in children, providing crucial data for infection control strategies.
Area of Science:
- Microbiology
- Genomics
- Infectious Diseases
Background:
- Enterococci are significant causes of healthcare-associated infections in children.
- Linezolid-non-susceptible enterococci (LNSE) pose a growing challenge to treating multidrug-resistant Gram-positive infections.
- Limited epidemiological and genomic data exist for pediatric LNSE.
Purpose of the Study:
- To investigate the epidemiology and genomics of linezolid-non-susceptible enterococci (LNSE) in a pediatric population.
- To identify resistance mechanisms and virulence factors in pediatric LNSE strains.
- To inform targeted prevention and control strategies for LNSE in children.
Main Methods:
- Analysis of 26 LNSE strains isolated from pediatric patients.
- Identification and characterization using MALDI-TOF MS, Vitek2 Compact, and micro-broth dilution.
- Molecular techniques including MLST, resistance/virulence gene detection, and pan-genome analysis.
Main Results:
- Enterococcus faecalis (88.5%) was the dominant species, with ST16 being the most prevalent sequence type.
- All analyzed strains carried the optrA and fexA genes, conferring resistance to linezolid.
- Pan-genome analysis of E. faecalis indicated an open genome with evidence of horizontal gene transfer.
Conclusions:
- This study provides essential epidemiological and genomic insights into pediatric LNSE.
- The findings highlight the genetic basis of linezolid resistance in pediatric enterococci.
- Data generated will aid in developing effective strategies to combat LNSE infections in children.
Abstract:
Enterococci are major opportunistic pathogens causing healthcare-associated infections in children. Linezolid, a WHO-designated critically important antibiotic for multidrug-resistant Gram-positive infections, is increasingly challenged by linezolid-non-susceptible enterococci (LNSE). Yet pediatric LNSE epidemiology and genomics data remain scarce, hindering targeted control. We analyzed 26 LNSE strains isolated from Children's Hospital, Zhejiang University School of Medicine (June 2020-July 2024) using MALDI-TOF MS, Vitek2 Compact, micro-broth dilution (for linezolid MIC), MLST, resistance/virulence gene detection, and pan-genome analysis (COG/KEGG annotation). Enterococcus faecalis (E. faecalis) dominated (23/26,88.5%) with ST16 as the major sequence type (ST) and four novel STs identified; all strains harbored optrA and fexA, with species-specific resistance/virulence gene profiles. The 23 E. faecalis strains exhibited an open pan-genome (b = 0.174725), indicating the possible existence of active horizontal gene transfer (HGT), with core, accessory, and unique genes showing distinct functional differentiation. These findings provide critical and robust empirical data to inform the development of targeted prevention and control strategies against LNSE in pediatric populations.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Genomics
Introduction to Epidemiology

